Affiliation:
1. Department of Chemical Engineering, University of Michigan, Ann Arbor, MI 48109, USA
Abstract
Virus-like particles (VLPs) have been proposed as an attractive tool in SARS-CoV-2 vaccine development, both as (1) a vaccine candidate with high immunogenicity and low reactogenicity and (2) a substitute for live virus in functional and neutralization assays. Though multiple SARS-CoV-2 VLP designs have already been explored in Sf9 insect cells, a key parameter ensuring VLPs are a viable platform is the VLP spike yield (i.e., spike protein content in VLP), which has largely been unreported. In this study, we show that the common strategy of producing SARS-CoV-2 VLPs by expressing spike protein in combination with the native coronavirus membrane and/or envelope protein forms VLPs, but at a critically low spike yield (~0.04–0.08 mg/L). In contrast, fusing the spike ectodomain to the influenza HA transmembrane domain and cytoplasmic tail and co-expressing M1 increased VLP spike yield to ~0.4 mg/L. More importantly, this increased yield translated to a greater VLP spike antigen density (~96 spike monomers/VLP) that more closely resembles that of native SARS-CoV-2 virus (~72–144 Spike monomers/virion). Pseudotyping further allowed for production of functional alpha (B.1.1.7), beta (B.1.351), delta (B.1.617.2), and omicron (B.1.1.529) SARS-CoV-2 VLPs that bound to the target ACE2 receptor. Finally, we demonstrated the utility of pseudotyped VLPs to test neutralizing antibody activity using a simple, acellular ELISA-based assay performed at biosafety level 1 (BSL-1). Taken together, this study highlights the advantage of pseudotyping over native SARS-CoV-2 VLP designs in achieving higher VLP spike yield and demonstrates the usefulness of pseudotyped VLPs as a surrogate for live virus in vaccine and therapeutic development against SARS-CoV-2 variants.
Funder
National Science Foundation
National Institutes of Health
MCubed program at the University of Michigan
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference74 articles.
1. (2023, July 10). WHO Coronavirus (COVID-19) Dashboard|WHO Coronavirus (COVID-19) Dashboard with Vaccination Data, Available online: https://covid19.who.int/.
2. SARS-CoV-2 variants, spike mutations and immune escape;Harvey;Nat. Rev. Microbiol.,2021
3. Magazine, N., Zhang, T., Wu, Y., McGee, M.C., Veggiani, G., and Huang, W. (2022). Mutations and Evolution of the SARS-CoV-2 Spike Protein. Viruses, 14.
4. Increased transmissibility of SARS-CoV-2 lineage B.1.1.7 by age and viral load;Lyngse;Nat. Commun.,2021
5. Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines;Araf;J. Med. Virol.,2022